Integrating AI with Neurogenetics: Applications in Precision Medicine for Neurological Disorders
Biomedical & Pharmacology Journal · 02.06.2026 · 01_Special issue (19) · 959
DOI: 10.13005/bpj/3403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 01.06.2026. Verfasst von Hriday Kumar Biswas und 6 weiteren Autor:innen. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Artificial Intelligence (AI) is revolutionizing the field of neurology by significantly enhancing disease detection, therapeutic strategies, and patient management. Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis have traditionally been challenging to diagnose and treat due to their complex and heterogeneous nature. Recent advancements in AI, particularly in machine learning and deep learning, enable the analysis of neuroimaging, electroencephalogram (EEG) signals, and genomic data with high precision, facilitating early and more accurate diagnoses. Beyond diagnostics, AI contributes to the development of personalized treatment plans by integrating a patient’s genetic information, medical history, and lifestyle factors. This personalized approach improves therapeutic outcomes and minimizes adverse effects. Wearable AI-powered devices further enhance care by allowing continuous, real-time monitoring of cognitive and motor functions, enabling timely clinical interventions and adjustments in treatment protocols. Moreover, AI is transforming the drug discovery landscape. It assists in identifying novel therapeutic targets, predicting drug responses, repurposing existing drugs, and optimizing clinical trial design, thus reducing the time and cost involved in bringing new treatments to market. Despite its enormous promise, the widespread clinical integration of AI faces challenges such as data privacy concerns, the need for transparent decision-making algorithms, and the establishment of standardized regulatory frameworks. This review explores the evolving applications of AI in neurogenetics and neurology, emphasizing its role in early diagnosis, precision medicine, long-term monitoring, and drug development. Continued interdisciplinary collaboration is essential to harness AI’s full potential in improving neurological healthcare outcomes.
Zitieren
APA
Biswas, H. K., Jha, K. K., Jakhmola, V., Morris, S., Pandey, P., Rawat, A., & Kumari, A. (2026). Integrating AI with Neurogenetics: Applications in Precision Medicine for Neurological Disorders. Biomedical & Pharmacology Journal, 01_Special issue(19), 959. https://doi.org/10.13005/bpj/3403
Vancouver
Biswas HK, Jha KK, Jakhmola V, Morris S, Pandey P, Rawat A, et al. Integrating AI with Neurogenetics: Applications in Precision Medicine for Neurological Disorders. Biomedical & Pharmacology Journal. 2026;01_Special issue(19):959. doi:10.13005/bpj/3403
BibTeX
@article{Biswas2026,
author = {Biswas, Hriday Kumar and Jha, Kanhaiya Kumar and Jakhmola, Vikash and Morris, Srishti and Pandey, Pallavi and Rawat, Anshika and Kumari, Akanksha},
title = {Integrating AI with Neurogenetics: Applications in Precision Medicine for Neurological Disorders},
journal = {Biomedical & Pharmacology Journal},
year = {2026},
volume = {01_Special issue},
number = {19},
pages = {959},
doi = {10.13005/bpj/3403}
}
EUVIMED